Intratumoral heterogeneity of c-KIT mutations in a feline splenic mast cell tumor and their functional effects on cell proliferation

被引:0
|
作者
Yuki Hasegawa
Kazuha Shosu
kanako Tsuji
Yumiko Shimoyama
Takako Shimokawa Miyama
Kenji Baba
Masaru Okuda
Kazuhito Itamoto
Masaya Igase
Takuya Mizuno
机构
[1] Yamaguchi University,Laboratory of Molecular Diagnostics and Therapeutics, Joint Faculty of Veterinary Medicine
[2] Yamaguchi University,Laboratory of Veterinary Internal Medicine, Joint Faculty of Veterinary Medicine
[3] IDEXX Laboratories,Laboratory of Small Animal Clinical Science, Joint Faculty of Veterinary Medicine
[4] Yamaguchi University,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
A cat was presented with mast cell tumors (MCTs) of the skin and spleen. During the initial diagnosis, the exon 8 mutation of c-KIT was detected in the masses from skin and spleen by a commercial laboratory test. Consequently, treatment with toceranib was started. After complete remission, because of recurrence on day 117, the spleen and skin tumors were removed, but the cat eventually died on day 191. The analysis of ten cDNA clones of the c-KIT gene cloned from the surgically removed spleen revealed that seven different cDNA patterns were included, indicating the heterogeneity of this gene in the splenic MCT. The seven cDNA nucleotide patterns can be classified into four protein sequence patterns. In addition to the previously known mutations in exon 8, we identified novel mutations in exons 9, 10, and 18; four amino acids deletion in exon 9, and a point mutation in exons 10 and 18. Mouse IL-3-dependent cell line, Ba/F3, was transduced with these mutant clones, and c-KIT phosphorylation and proliferation assays were performed. We found that certain mutations affected the c-KIT phosphorylation status and cell proliferation. This suggests that heterogeneity among the population of tumor cells exists in MCTs, and that the dominant clones of this heterogeneity may contribute to the subsequent tumor cell growth.
引用
收藏
相关论文
共 50 条
  • [41] Functional and phenotypic studies of two variants of a human mast cell line with a distinct set of mutations in the c-kit proto-oncogene
    Sundström, M
    Vliagoftis, H
    Karlberg, P
    Butterfield, JH
    Nilsson, K
    Metcalfe, DD
    Nilsson, G
    IMMUNOLOGY, 2003, 108 (01) : 89 - 97
  • [42] INDUCTION OF MAST-CELL PROLIFERATION, MATURATION, AND HEPARIN SYNTHESIS BY THE RAT C-KIT LIGAND, STEM-CELL FACTOR
    TSAI, M
    TAKEISHI, T
    THOMPSON, H
    LANGLEY, KE
    ZSEBO, KM
    METCALFE, DD
    GEISSLER, EN
    GALLI, SJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (14) : 6382 - 6386
  • [43] Canine intestinal mast cell tumor with c-kit exon 8 mutation responsive to imatinib therapy
    Kobayashi, Masato
    Sugisaki, Osamu
    Ishii, Noriko
    Yamada, Osamu
    Ito, Keita
    Kuroki, Shiori
    Sasaki, Yu
    Ono, Kenichiro
    Washizu, Tsukimi
    Bonkobara, Makoto
    VETERINARY JOURNAL, 2012, 193 (01): : 264 - 267
  • [44] Investigating Associations Between Proliferation Indices, C-kit, and Lymph Node Stage in Canine Mast Cell Tumors
    Krick, Erika Lauren
    Kiupel, Matti
    Durham, Amy C.
    Thaiwong, Tuddow
    Brown, Dorothy C.
    Sorenmo, Karin U.
    JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION, 2017, 53 (05) : 258 - 264
  • [45] A case of de novo aleukemic mast cell leukemia without c-KIT mutations in exons 8 and 17
    Park, S. H.
    Chi, H-S
    Cho, Y-U
    Jang, S.
    Park, C-J
    Lee, J-H
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2014, 36 (04) : E44 - E46
  • [46] ACTIVATING MUTATIONS OF THE C-KIT PROTOONCOGENE IDENTIFIED IN A HUMAN MAST-CELL LEUKEMIA-CELL LINE, HMC-1
    KITAYAMA, H
    KANAKURA, Y
    FURITSU, T
    TSUJIMURA, T
    BUTTERFIELD, KJH
    ORITANI, K
    IKEDA, H
    SUGAHARA, H
    KANAYAMA, Y
    KITAMURA, Y
    MATSUZAWA, Y
    BLOOD, 1993, 82 (10) : A120 - A120
  • [47] Effects of nitric oxide on stem cell factor-induced mast cell activation and surface expression of c-kit
    Button, CL
    Galli, SJ
    Coleman, JW
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124
  • [48] Evaluation of the kinase domain of c-KIT in canine cutaneous mast cell tumors
    Webster, JD
    Kiupel, M
    Yuzbasiyan-Gurkan, V
    BMC CANCER, 2006, 6 (1)
  • [49] Characterization of a mast cell line that lacks the extracellular domain of membrane c-kit
    Mekori, YA
    Oh, CK
    Dastych, J
    Goff, JP
    Adachi, S
    Bianchine, PJ
    Worobec, A
    Semere, T
    Pierce, JH
    Metcalfe, DD
    IMMUNOLOGY, 1997, 90 (04) : 518 - 525
  • [50] Evaluation of an intron deletion in the c-kit gene of canine mast cell tumors
    Reguera, MJ
    Ferrer, L
    Rabanal, RM
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2002, 63 (09) : 1257 - 1261